Awards

Awards

  • Hospital is fully accredited by The Joint Commission (TJC)
  • Hospital is accredited by The Joint Commission in Medicare/Medicaid Certification- based long term care
  • The Joint Commission's Gold Seal of Approval® and the American Heart Association/American Stroke Association's Heart-Check mark for Advanced Certification for Primary Stroke Centers
  • Los Angeles County Department of Health Services, Emergency Medical Services Agency, Approved Stroke Center
  • Laboratory Services are fully accredited by the College of American Pathologists (CAP)
  • Imaging services accredited by the American College of Radiology (ACR)
  • 2016 and 2017 Patient Safety Excellence Award - Healthgrades
  • 2017 American Heart Association/American Stroke Association's Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award with Target: Stroke Honor Roll
  • 2017 Women’s Choice Award® as one of America’s Best Hospitals for Emergency Care
  • Joint Commission Top Performer on Key Quality Measures 2013, 2014, 2015 – Pneumonia 2010, 2011
  • Received an A for Hospital Safety by The Leapfrog Group 2012, 2016, 2017
  • Received recognition as an Emergency Department Approved for Pediatrics facility from the Los Angeles County Department of Health Services
  • Mayor Garcetti has awarded EHMC with a Certificate of Congratulations from the City of Los Angeles for the launch of Southern California's first Geriatric Emergency Room "Senior ER"
  • Assemblyman Kevin De Leon has awarded EHMC with a Certificate of Recognition from the California Legislature Assembly 2009

The American Heart Association and American Stroke Association recognize this hospital for achieving 85% or higher compliance with all Get With The Guidelines - Stroke achievement indicators for two or more consecutive 12-month periods and acheive 75% or higher compliance with five of eight Get With The Guidelines - Stroke Quality measures.

To qualify for the Target: Stroke Honor Roll, hospitals must meet quality measures developed to reduce the time between the patient's arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only U.S. FDA approved drug to treat ischemic stroke.